These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


220 related items for PubMed ID: 33106368

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Different neurological and physiological profiles in POEMS syndrome and chronic inflammatory demyelinating polyneuropathy.
    Nasu S, Misawa S, Sekiguchi Y, Shibuya K, Kanai K, Fujimaki Y, Ohmori S, Mitsuma S, Koga S, Kuwabara S.
    J Neurol Neurosurg Psychiatry; 2012 May; 83(5):476-9. PubMed ID: 22338030
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Update on the Diagnosis and Treatment of POEMS (Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes) Syndrome: A Review.
    Khouri J, Nakashima M, Wong S.
    JAMA Oncol; 2021 Sep 01; 7(9):1383-1391. PubMed ID: 34081097
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Clinical and electrophysiological profiles in early recognition of polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes syndrome.
    Wang Q, Liu P, Ji LL, Wu S, Feng GD, Wang X, Dong JH.
    Chin Med J (Engl); 2019 Jul 20; 132(14):1666-1672. PubMed ID: 31268911
    [Abstract] [Full Text] [Related]

  • 9. POEMS syndrome with Guillan-Barre syndrome-like acute onset: a case report and review of neurological progression in 30 cases.
    Isose S, Misawa S, Kanai K, Shibuya K, Sekiguchi Y, Nasu S, Fujimaki Y, Noto Y, Nakaseko C, Kuwabara S.
    J Neurol Neurosurg Psychiatry; 2011 Jun 20; 82(6):678-80. PubMed ID: 20562460
    [Abstract] [Full Text] [Related]

  • 10. Blink R1 latency utility in diagnosis and treatment assessment of polyradiculoneuropathy-organomegaly-endocrinopathy-monoclonal protein-skin changes and chronic inflammatory demyelinating polyradiculoneuropathy.
    Wang W, Litchy WJ, Mauermann ML, Dyck PJB, Dispenzieri A, Mandrekar J, Dyck PJ, Klein CJ.
    Muscle Nerve; 2018 Jan 20; 57(1):E8-E13. PubMed ID: 28646568
    [Abstract] [Full Text] [Related]

  • 11. POEMS neuropathy: optimising diagnosis and management.
    Keddie S, D'Sa S, Foldes D, Carr AS, Reilly MM, Lunn MPT.
    Pract Neurol; 2018 Aug 20; 18(4):278-290. PubMed ID: 29511110
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. POEMS Syndrome: 2019 Update on diagnosis, risk-stratification, and management.
    Dispenzieri A.
    Am J Hematol; 2019 Jul 20; 94(7):812-827. PubMed ID: 31012139
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Diagnosis and management of POEMS syndrome].
    Ohwada C.
    Rinsho Ketsueki; 2024 Jul 20; 65(9):1033-1041. PubMed ID: 39358258
    [Abstract] [Full Text] [Related]

  • 16. [POEMS-syndrome].
    Arkhipov IE, Vergunova IY, Malkova NA, Korobko DS.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2023 Jul 20; 123(7. Vyp. 2):15-21. PubMed ID: 37560829
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Safety and efficacy of thalidomide in patients with POEMS syndrome: a multicentre, randomised, double-blind, placebo-controlled trial.
    Misawa S, Sato Y, Katayama K, Nagashima K, Aoyagi R, Sekiguchi Y, Sobue G, Koike H, Yabe I, Sasaki H, Watanabe O, Takashima H, Nishizawa M, Kawachi I, Kusunoki S, Mitsui Y, Kikuchi S, Nakashima I, Ikeda S, Kohara N, Kanda T, Kira J, Hanaoka H, Kuwabara S, Japanese POEMS Syndrome for Thalidomide (J-POST) Trial Study Group.
    Lancet Neurol; 2016 Oct 20; 15(11):1129-37. PubMed ID: 27496680
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [POEMS syndrome diagnosed by detection of M-protein on immunofixation and increased level of vascular endothelial growth factor].
    Hattori Y, Taguchi J, Imai N, Wasano K, Matsuura S, Koharazawa H, Ishigatsubo Y, Fujisawa S.
    Rinsho Ketsueki; 2011 Apr 20; 52(4):219-22. PubMed ID: 21566409
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.